Article Versions Notes

Swetha M, Keerthana CK, Rayginia TP, Nath LR, Haritha NH, Shabna A, Kalimuthu K, Thangarasu AK, Aiswarya SU, Jannet S, et al. Augmented Efficacy of Uttroside B over Sorafenib in a Murine Model of Human Hepatocellular Carcinoma. Pharmaceuticals. 2022; 15(5):636. https://doi.org/10.3390/ph15050636

Swetha, Mundanattu, Chenicheri K. Keerthana, Tennyson P. Rayginia, Lekshmi R. Nath, Nair Hariprasad Haritha, Anwar Shabna, Kalishwaralal Kalimuthu, Arun K. Thangarasu, Sreekumar U. Aiswarya, Somaraj Jannet, and et al. 2022. "Augmented Efficacy of Uttroside B over Sorafenib in a Murine Model of Human Hepatocellular Carcinoma" Pharmaceuticals 15, no. 5: 636. https://doi.org/10.3390/ph15050636

Swetha, M., Keerthana, C. K., Rayginia, T. P., Nath, L. R., Haritha, N. H., Shabna, A., Kalimuthu, K., Thangarasu, A. K., Aiswarya, S. U., Jannet, S., Pillai, S., Harikumar, K. B., Sundaram, S., Anto, N. P., Wu, D. H., Lankalapalli, R. S., Towner, R., Isakov, N., Deepa, S. S., & Anto, R. J. (2022). Augmented Efficacy of Uttroside B over Sorafenib in a Murine Model of Human Hepatocellular Carcinoma. Pharmaceuticals, 15(5), 636. https://doi.org/10.3390/ph15050636